Quantum Biopharma (QNTM) Short-term Investments (2019 - 2026)
Quantum Biopharma (QNTM) posted Short-term Investments of $222906.0 for Q1 2026, down 51.45% sequentially from $459080.0 in Q4 2025, and up 968.17% YoY from $20868.0 in Q1 2025.
Quantum Biopharma (QNTM) Short-term Investments (2019 - 2026) Analysis & Trends
Quantum Biopharma has reported Short-term Investments for 8 years, with the latest figure at $222906.0 in Q1 2026.
- Quarterly Short-term Investments rose 968.17% year-over-year to $222906.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $222906.0 (up 968.17% YoY) and the FY2025 annual result came in at $459080.0, down 61.82% from the prior year.
- Short-term Investments declined to $222906.0 in Q1 2026 per QNTM's latest filing, from $459080.0 in the prior quarter.
- Over five years, Short-term Investments peaked at $3.5 million in Q3 2024 and troughed at $20868.0 in Q1 2025.
- A 5-year average of $663517.0 and a median of $499641.5 in 2022 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2024 and 2026: Short-term Investments tumbled 96.02% in 2024, then surged 968.17% in 2026.
- Over 5 years, Short-term Investments stood at $365092.0 in 2022, then surged by 102.58% to $739600.0 in 2023, then soared by 62.57% to $1.2 million in 2024, then tumbled by 61.82% to $459080.0 in 2025, then tumbled by 51.45% to $222906.0 in 2026.
- According to Business Quant data, Short-term Investments over the past three periods registered $222906.0, $459080.0, and $636761.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 210,708.00 |
| Mar 31, 2026 | 222,906.00 |
| Dec 31, 2025 | 459,080.00 |
| Sep 30, 2025 | 636,761.00 |
| Jun 30, 2025 | 30,786.00 |
| Mar 31, 2025 | 20,868.00 |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 3.49 Mn |
| Jun 30, 2024 | 21,918.00 |
| Sep 30, 2023 | 739,600.00 |
| Jun 30, 2023 | 550,283.00 |
| Mar 31, 2023 | 650,334.00 |
| Sep 30, 2022 | 365,092.00 |
| Jun 30, 2022 | 363,634.00 |
| Mar 31, 2022 | 540,203.00 |
| Dec 31, 2021 | 158,036.00 |
| Sep 30, 2021 | 1.50 Mn |
| Jun 30, 2021 | 2.26 Mn |
| Mar 31, 2021 | 2.64 Mn |
| Sep 30, 2020 | 1.20 Mn |